Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Apr 30, 2026
Reporting period
Not applicable
Filed with the SEC
May 4, 2026
DirectorGrant / award
Context
Classification
grant award
Code A — grant or award
Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0000882095-26-000010
Filed / recorded
May 4, 2026, 8:40 PM UTC
Added to OQRO
Oct 2, 2026, 12:27 PM UTC
Parser
form4-xml-v1
Data quality
Verified: identifiers matched exactly
Issuer
GILEAD SCIENCES, INC.
Issuer CIK
882095
Ticker
GILD
Reporting person
Jeffrey Bluestone
Relationship
Director
Security
Common Stock
Table
Non-derivative (Table I)
Transaction date
Apr 30, 2026
Transaction code
A
Shares / units
1,146
Price per share
$0.00
Acquired / disposed
Acquired (A)
Shares owned after
10,066
Ownership form
Direct
Amendment
No
Footnotes from the filing
Represents 1,146 restricted stock units ("RSUs") granted under the Gilead Sciences, Inc. 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. The RSUs vested immediately upon the grant date of April 30, 2026.
